Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Development of a Stacked Ensemble Model for Risk Stratification of Chronic Gvhd after Allogeneic HSCT: Trump Cohort Study

Blood (2023) 142 (Supplement 1): 3561.

https://doi.org/10.1182/blood-2023-173779

Published: 2023

Journal Articles

Outcomes after Hematopoietic Cell Transplantation for T-Lineage Acute Lymphoblastic Leukemia and Lymphoma: A Cooperative Study from the Adult Acute Lymphoblastic Leukemia Working Group and the Adult Malignant Lymphoma Working Group of the Japanese Society for Transplantation and Cellular Therapy

Blood (2023) 142 (Supplement 1): 899.

https://doi.org/10.1182/blood-2023-184709

Published: 2023

Journal Articles

Impact of Letermovir Prophylaxis for Cytomegalovirus Reactivation on Post-Transplant Outcomes 100 Days before and after Allogeneic Hematopoietic Cell Transplantation

Blood (2023) 142 (Supplement 1): 4898.

https://doi.org/10.1182/blood-2023-180906

Published: 2023

Journal Articles

Significance of Marker Chromosome on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for AML

Kyoko Fuse, MD PhD, Masayoshi Masuko, MD PhD, Shohei Mizuno, MD PhD, Kaito Harada, MD, Naoyuki Uchida, MD PhD, Noriko Doki, MD PhD, Takahiro Fukuda, Masatsugu Tanaka, MD, Yukiyasu Ozawa, MD PhD, Kazuhiro Ikegame, MD PhD, Tetsuya Eto, MD PhD, Yoshinobu Kanda, MD PhD, Tatsuo Ichinohe, Yoshiko Atsuta, MD PhD, Masamitsu Yanada, MD PhD

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-138979

Published: 2020

Journal Articles

The Optimal Treatment Strategy for Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in First Complete Remission in the Era of High-Intensity Chemotherapy

Blood (2019) 134 (Supplement_1): 4589.

https://doi.org/10.1182/blood-2019-126012

Published: 2019

Journal Articles

Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Myeloid Leukemia in Japan

Shohei Mizuno, MD PhD, Masamitsu Yanada, Koji Kawamura, Shingo Yano, MD PhD, Masayoshi Masuko, MD, Naoyuki Uchida, MD PhD, Yukiyasu Ozawa, MD PhD, Koji Iwato, Kazuteru Ohashi, MD PhD, Kazuhiro Ikegame, MD PhD, Sung-Won Kim, MD PhD, Masatsugu Tanaka, MD, Tetsuya Eto, MD PhD, Yoshinobu Kanda, MD PhD, Takahiro Fukuda, Yoshiko Atsuta, MD PhD, Akiyoshi Takami, MD

Blood (2019) 134 (Supplement_1): 2045.

https://doi.org/10.1182/blood-2019-122801

Published: 2019

Journal Articles

Comparison of Outcomes of Allogeneic Hematopoietic Cell Transplantation for Primary Myelofibrosis Among Stem Cell Source Groups

Makoto Murata, MD PhD, Katsuto Takenaka, MD PhD, Naoyuki Uchida, MD PhD, Yukiyasu Ozawa, Kazuteru Ohashi, MD PhD, Sung-Won Kim, MD PhD, Kazuhiro Ikegame, MD PhD, Yoshiko Atsuta, MD PhD, Makoto Hirokawa, MD PhD, Takahiro Fukuda, Takeshi Kondo, MD PhD

Blood (2018) 132 (Supplement 1): 3466.

https://doi.org/10.1182/blood-2018-99-114745

Published: 2018

Journal Articles

Hematopoietic Stem-Cell Transplantation in Children with Refractory Acute Myeloid Leukemia

Yasuhiro Okamoto, MD, Kazuko Kudo, MD PhD, Ken Tabuchi, MD, Daisuke Tomizawa, MD PhD, Takashi Taga, MD PhD, Hiroaki Goto, MD, Hiromasa Yabe, MD, PhD, Yozo Nakazawa, MD, PhD, Katsuyoshi Koh, MD, Kazuhiro Ikegame, MD PhD, Nao Yoshida, MD PhD, Naoyuki Uchida, MD PhD, Kenichiro Watanabe, MD PhD, Yuuki Koga, MD PhD, Masami Inoue, MD, Koji Kato, MD PhD, Yoshiko Atsuta, MD PhD, Hiroyuki Ishida, MD, PhD

Blood (2018) 132 (Supplement 1): 4632.

https://doi.org/10.1182/blood-2018-99-111322

Published: 2018

Journal Articles

Who Is the Best Donor for the Second Transplant?: HLA Discrepancy between Graft and Host Rather Than That Graft and First Donor May Impact the Second Transplant Outcome from the JSHCT

Yoshinobu Maeda, MD PhD, Tomotaka Ugai, MD, Eisei Kondo, Kazuhiro Ikegame, MD PhD, Makoto Murata, MD PhD, Naoyuki Uchida, MD PhD, Toshihiro Miyamoto, MD PhD, Satoshi Takahashi, MD PhD, Kazuteru Ohashi, MD PhD, Hirohisa Nakamae, MD PhD, Makoto Hirokawa, MD PhD, Tatsuo Ichinohe, MD PhD, Yoshiko Atsuta, MD PhD, Yoshinobu Kanda, MD PhD, Junya Kanda, MD

Blood (2018) 132 (Supplement 1): 4635.

https://doi.org/10.1182/blood-2018-99-112796

Published: 2018

Journal Articles

MCP-1 and VCAM-1 As Pathological Markers In a Patient With Infection Induced Hemophagocytic Syndrome After Stem Cell Transplantation

Kunio Hayashi, PhD/MD, Kazuhiro Ikegame, PhD/MD, Masafumi Ito, PhD/MD, Shosaku Nomura, PhD/MD

Blood (2013) 122 (21): 5465.

https://doi.org/10.1182/blood.V122.21.5465.5465

Published: 2013

Journal Articles

Novel Strategy for MDS with Thalidomide, 5-Azacitidine and Stem Cell Transplantaion

Kunio Hayashi, M.D., Ph.D., Kazuhiro Ikegame, MD, PhD, Hiroyasu Ogawa, M.D., Ph.D.

Blood (2012) 120 (21): 4960.

https://doi.org/10.1182/blood.V120.21.4960.4960

Published: 2012

Journal Articles

FDG-PET/CT Early After 90Y-Ibritumomab Tiuxetan Therapy Predicts Outcome in Relapsed or Refractory Indolent B-Cell Lymphoma

Masaya Okada, MD, PhD, Yoshihiro Fujimori, MD, PhD, Naohiko Oku, MD, PhD, Akira Tamekane, MD, PhD, Toshiro Takafuta, MD, PhD, Toshiyuki Nakajima, MD, Tazuko Tokugawa, MD, Akihiro Sawada, MD, Shin-ichi Ishii, MD, Katsuji Kaida, MD, Kazuhiro Ikegame, MD, PhD, Toshihiro Soma, MD, PhD, Hiroyasu Ogawa, MD, PhD

Blood (2012) 120 (21): 3648.

https://doi.org/10.1182/blood.V120.21.3648.3648

Published: 2012

Journal Articles

A Novel Regimen of Unmanipulated HLA-Haploidentical Transplantation Using a Small Dose of Anti-T-Lymphocyte Globulin for Patients in High Tumor Burden

Shinichi Ishii, MD, Kazuhiro Ikegame, MD, PhD, Katsuji Kaida, MD, Satoshi Yoshihara, MD, PhD, Masaya Okada, MD, PhD, Ruri Kato, MD, Takayuki Inoue, MD, Hiroya Tamaki, MD, PhD, Yoshihiro Fujimori, MD, PhD, Toshihiro Soma, Hiroyasu Ogawa, MD, PhD

Blood (2012) 120 (21): 4203.

https://doi.org/10.1182/blood.V120.21.4203.4203

Published: 2012

Journal Articles

Unmanipulated HLA-Haploidentical (2-3 antigen-mismatched) Stem Cell Transplantation Using Myeloablative or Reduced-Intensity Preconditioning Regimen,

Katsuji Kaida, MD, Kazuhiro Ikegame, MD, PhD, Satoshi Yoshihara, MD, PhD, Kyoko Taniguchi, MD, Shinichi Ishii, MD, Ruri Kato, MD, Takayuki Inoue, MD, Masaya Okada, MD, PhD, Hiroya Tamaki, MD, PhD, Tatsuya Fujioka, MD, PhD, Toshihiro Soma, MD, PhD, Hiroyasu Ogawa, MD, PhD

Blood (2011) 118 (21): 4117.

https://doi.org/10.1182/blood.V118.21.4117.4117

Published: 2011

Journal Articles

Mechanism of Marked Reduction In the Severity of Graft-Versus-Host Disease by Reduced-Intensity Conditioning In Murine MHC-Haploidentical BMT Model

Takayuki Inoue, Kazuhiro Ikegame, Satoshi Yoshihara, Katsuji Kaida, Kyoko Taniguchi, Hiroya Tamaki, Tatsuya Fujioka, Masaya Okada, Ruri Kato, Yoko Yamamoto, Toshihiro Soma, Hiroyasu Ogawa

Blood (2010) 116 (21): 4707.

https://doi.org/10.1182/blood.V116.21.4707.4707

Published: 2010

Journal Articles

The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia

Hiroyasu Ogawa, Hiroya Tamaki, Kazuhiro Ikegame, Toshihiro Soma, Manabu Kawakami, Akihiro Tsuboi, Eui Ho Kim, Naoki Hosen, Masaki Murakami, Tatsuya Fujioka, Tomoki Masuda, Yuki Taniguchi, Sumiyuki Nishida, Yusuke Oji, Yoshihiro Oka, Haruo Sugiyama

Blood (2003) 101 (5): 1698–1704.

https://doi.org/10.1182/blood-2002-06-1831

Published: 2003

NARROW

Development of a Stacked Ensemble Model for Risk Stratification of Chronic Gvhd after Allogeneic HSCT: Trump Cohort Study

Outcomes after Hematopoietic Cell Transplantation for T-Lineage Acute Lymphoblastic Leukemia and Lymphoma: A Cooperative Study from the Adult Acute Lymphoblastic Leukemia Working Group and the Adult Malignant Lymphoma Working Group of the Japanese Society for Transplantation and Cellular Therapy

Impact of Letermovir Prophylaxis for Cytomegalovirus Reactivation on Post-Transplant Outcomes 100 Days before and after Allogeneic Hematopoietic Cell Transplantation

Significance of Marker Chromosome on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for AML

The Optimal Treatment Strategy for Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in First Complete Remission in the Era of High-Intensity Chemotherapy

Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Myeloid Leukemia in Japan

Comparison of Outcomes of Allogeneic Hematopoietic Cell Transplantation for Primary Myelofibrosis Among Stem Cell Source Groups

Hematopoietic Stem-Cell Transplantation in Children with Refractory Acute Myeloid Leukemia

Who Is the Best Donor for the Second Transplant?: HLA Discrepancy between Graft and Host Rather Than That Graft and First Donor May Impact the Second Transplant Outcome from the JSHCT

MCP-1 and VCAM-1 As Pathological Markers In a Patient With Infection Induced Hemophagocytic Syndrome After Stem Cell Transplantation

Novel Strategy for MDS with Thalidomide, 5-Azacitidine and Stem Cell Transplantaion

FDG-PET/CT Early After 90Y-Ibritumomab Tiuxetan Therapy Predicts Outcome in Relapsed or Refractory Indolent B-Cell Lymphoma

A Novel Regimen of Unmanipulated HLA-Haploidentical Transplantation Using a Small Dose of Anti-T-Lymphocyte Globulin for Patients in High Tumor Burden

Unmanipulated HLA-Haploidentical (2-3 antigen-mismatched) Stem Cell Transplantation Using Myeloablative or Reduced-Intensity Preconditioning Regimen,

Mechanism of Marked Reduction In the Severity of Graft-Versus-Host Disease by Reduced-Intensity Conditioning In Murine MHC-Haploidentical BMT Model

The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only